These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25347429)

  • 21. POEMS syndrome with undetectable M-protein: a case report and literature review.
    Xue HY; Zhou L; Yuan QZ; Zhang Y; Hao YQ; Chen SW; Wang HK; Wei F
    Diagn Pathol; 2024 Jun; 19(1):74. PubMed ID: 38849857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
    Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
    Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
    Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
    Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
    Kanai K; Kuwabara S; Misawa S; Hattori T
    Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
    Zagouri F; Kastritis E; Gavriatopoulou M; Sergentanis TN; Psaltopoulou T; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2014 Sep; 55(9):2018-23. PubMed ID: 24295131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POEMS syndrome, congestive heart failure and thalidomide -food for thought.
    Tageja N
    Intern Med; 2010; 49(17):1919; author reply 1921. PubMed ID: 20823658
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
    Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
    Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
    Imai N; Taguchi J; Yagi N; Konishi T; Serizawa M; Kobari M
    Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POEMS syndrome: a rare cause of exudative ascites and chronic peripheral neuropathy.
    Al-Mayoof O; Al Sughaiyer H; Abuomar W; Khan M
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28637843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
    Autore F; Innocenti I; Luigetti M; Piccirillo N; Sora F; Chiusolo P; Sica S; Bacigalupo A; Laurenti L
    Hematol Oncol; 2018 Apr; 36(2):392-398. PubMed ID: 28913957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POEMS Syndrome: Therapeutic Options.
    Jaccard A
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
    Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
    Gao XM; Yu YY; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
    Ann Hematol; 2021 Nov; 100(11):2755-2761. PubMed ID: 34331562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple angiogenetic factors are upregulated in POEMS syndrome.
    Yamada Y; Sawai S; Misawa S; Kanai K; Shibuya K; Mori M; Moriya J; Sogawa K; Yamamoto H; Beppu M; Taniguchi J; Nakaseko C; Nomura F; Kuwabara S
    Ann Hematol; 2013 Jan; 92(2):245-8. PubMed ID: 23053181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
    Paranavitane S; Gooneratne L; Chang T
    J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
    BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment strategy for POEMS syndrome].
    Kawamura N; Kira J
    Brain Nerve; 2008 Jun; 60(6):621-6. PubMed ID: 18567357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
    Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
    Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
    Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
    J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
    Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.